• 제목/요약/키워드: Rh factor

검색결과 246건 처리시간 0.036초

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Activates Pro-Survival Signaling Pathways, Nuclear Factor-${\kappa}B$ and Extracellular Signal-Regulated Kinase 1/2 in Trophoblast Cell Line, JEG-3

  • Ka Hakhyun
    • Reproductive and Developmental Biology
    • /
    • 제29권2호
    • /
    • pp.101-108
    • /
    • 2005
  • Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) is a well-known inducer of apoptotic cell death in many tumor cells. 1RAIL is expressed in human placenta, and cytotrophoblast cells express 1RAIL receptors. However, the role of TRAIL in human placentas and cytotrophoblast cells is not. well understood. In this study a trophoblast cell line, JEG-3, was used as a model system to examine the effect of TRAIL. on key intracellular signaling pathways involved in the control of trophoblastic cell apoptosis and survival JEG-3 cells expressed receptors for 1RAIL, death receptor (DR) 4, DR5, decoy receptor (OcR) 1 and DeR2. Recombinant human TRAIL (rhTRAIL) did not have a cytotoxic effect determined by MIT assay and did not induce apoptotic cell death determined by poly-(ADP-ribose) polymerase cleavage assay. rhTRAIL induced a rapid and transient nuclear translocation of nuclear $factor-{\kappa}B(NF-{\kappa}B)$ determined by immunoblotting using nuclear protein extracts. rhTRAIL rapidly activated extracellular signal-regulated protein kinase (ERK) 1/2 as determined by immnoblotting for phospho-ERK1/2. However, c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (p38MAPK) and Akt (protein kinase B) were not activated by rhTRAIL. The ability of 1RAIL to induce $NF-{\kappa}B$ and ERK1/2 suggests that interaction between TRAIL and its receptors may play an important role in trophoblast cell function during pregnancy.

재조합 표피성장인자가 방사선이 조사된 섬유아세포 증식에 미치는 영향 (Effects of Recombinant Human Epidermal Growth Factor on the Proliferationand Radiation Survival of Human Fibroblast Cell Lines in Vitro)

  • 김현숙;강기문;이상욱;나재범;채규영
    • Radiation Oncology Journal
    • /
    • 제24권3호
    • /
    • pp.179-184
    • /
    • 2006
  • 목 적: 재조합 표피성장인자는(rhEGF) 다양한 표피와 상피 세포의 증식을 자극하는 것으로 알려져 있다. 본 연구에서는 방사선이 조사된 섬유아세포의 증식에 rhEGF의 효과를 알아보고자 하였다. 대상 및 방법: 인간에서 기원한 섬유아세포를 초대배양(primary culture)한 세포를 이용하였다. 대웅제약에서 유전자 재조합하여 대장균에서 발현하여 생산한 rhEGF를 제공 받아 사용하였다. 방사선 조사는 4 MV 선형가속기(CLINAC 600C, Varian, Palo Alto, CA, USA)를 이용하여 분당 2 Gy 내외의 선량률로 균일하게 조사하였다. 조사된 방사선량은 8 Gy이었다. 생존세포수는 trypan blue 염색법을 이용하였고, rhEGF에 의한 세포주기의 변화를 관찰하기 위하여 유세포 분석법을 시행하였다. 결 과: 4 Gy의 방사선을 조사한 후 7일째까지 생존 세포수를 trypan blue 염색법을 이용하여 측정한 결과 모든 rhEGF 농도(1.0 nM, 10 nM, 100 nM, 1,000 nM )에서 방사선 조사 단독군보다 생존세포 수가 많았다. 방사선을 조사하지 않은 섬유아세포에서 rhEGF를 10 nM처리한 후 FACS scan을 시행한 결과 세포주기 중에서 S기 비율이 증가하였다. 결 론: 방사선이 조사된 섬유아세포에서 rhEGF를 투여하면 rhEGF를 투여하지 않은 섬유아세포에 비해서 세포증식이 가속됨을 확인할 수 있었다.

Separation of Rh(III) from the Mixed Chloride Solutions Containing Pt(IV) and Pd(II) by Extraction with Alamine336

  • Sun, Panpan;Lee, Myung-Ho;Lee, Man-Seung
    • Bulletin of the Korean Chemical Society
    • /
    • 제31권7호
    • /
    • pp.1945-1950
    • /
    • 2010
  • Solvent extraction experiments of Pt(IV), Pd(II) and Rh(III) by Alamine336 were performed from the mixed chloride solutions. In the HCl concentration range from 1 to 5 M, most of Pt and Pd were extracted from the mixed solutions. However, the extraction percentage of Rh was much smaller than that of Pt and Pd. Lower concentration of Alamine336 in strong HCl solution led to higher separation factor of Rh from Pt and Pd. Adding $SnCl_2$ to the mixed solutions increased the extraction percentage of Rh, while the extraction percentage of Pt and Pd was little affected. Our results showed that selective separation of Rh or coextraction of the three platinum group metals from the mixed solution would be possible by adjusting the extraction conditions.

Inhibitory Effect of Ginsenoside Rg5 and Its Metabolite Ginsenoside Rh3 in an Oxazolone-Induced Mouse Chronic Dermatitis Model

  • Shin, Yong-Wook;Bae, Eun-Ah;Kim, Dong-Hyun
    • Archives of Pharmacal Research
    • /
    • 제29권8호
    • /
    • pp.685-690
    • /
    • 2006
  • The effect of a main constituent ginsenoside Rg5 isolated from red ginseng and its metabolite ginsenoside Rh3 in a chronic dermatitis model was investigated. Ginsenosides Rg5 and Rh3 suppressed swelling of oxazolone-induced mouse ear contact dermatitis. These ginsenosides also reduced mRNA expressions of cyclooxygenase-2, interleukin $(IL)-1{\beta}$, tumor necrosis factor $(TNF)-{\alpha}$ and interferon $(IFN)-{\gamma}$. The inhibition of ginsenoside Rh3 was more potent than that of ginsenoside Rg5. These findings suggest that ginsenoside Rh3 metabolized from ginsenoside Rg5 may improve chronic dermatitis or psoriasis by the regulation of $IL-1{\beta}$ and $TNF-{\alpha}$ produced by macrophage cells and of $IFN-{\gamma}$ produced by Th cells.

Relationships between Skin Cancers and Blood Groups - Link between Non-melanomas and ABO/Rh Factors

  • Cihan, Yasemin Benderli;Baykan, Halit;Kavuncuoglu, Erhan;Mutlu, Hasan;Kucukoglu, Mehmet Burhan;Ozyurt, Kemal;Oguz, Arzu
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권7호
    • /
    • pp.4199-4203
    • /
    • 2013
  • Background: This investigation focused on possible relationships between skin cancers and ABO/Rh blood groups. Materials and Methods: Between January 2005 and December 2012, medical data of 255 patients with skin cancers who were admitted to Kayseri Training and Research Hospital, Radiation Oncology and Plastic Surgery Outpatient Clinics were retrospectively analyzed. Blood groups of these patients were recorded. The control group consisted of 25701 healthy volunteers who were admitted to Kayseri Training and Research Hospital, Blood Donation Center between January 2010 and December 2011. The distribution of the blood groups of the patients with skin cancers was compared to the distribution of ABO/Rh blood groups of healthy controls. The association of the histopathological subtypes of skin cancer with the blood groups was also investigated. Results: Of the patients, 50.2% had A type, 26.3% had O type, 16.1% had B type, and 7.5% had AB blood group with a positive Rh (+) in 77.3%. Of the controls, 44.3% had A type, 31.5% had 0 type, 16.1% had B type, and 8.1% had AB blood group with a positive Rh (+) in 87.8%. There was a statistically significant difference in the distribution of blood groups and Rh factors (A Rh (-) and 0 Rh positive) between the patients and controls. A total of 36.8% and 20.4% of the patients with basal cell carcinoma (BCC) had A Rh (+) and B Rh (+), respectively, while 39.2% and 27.6% of the controls had A Rh (+) and B Rh (+), respectively. A significant relationship was observed between the patients with BCC and controls in terms of A Rh (-) (p=0.001). Conclusion: Our study results demonstrated that there is a significant relationship between non-melanoma skin cancer and ABO/Rh factors.

수산화라디칼 소모인자를 이용한 자외선/과산화수소공정의 효율적인 운전 조건도출 (Determination of Efficient Operating Condition of UV/H2O2 Process Using the OH Radical Scavenging Factor)

  • 김선백;권민환;윤여준;정유미;황태문;강준원
    • 대한환경공학회지
    • /
    • 제36권8호
    • /
    • pp.534-541
    • /
    • 2014
  • 본 논문은 먹는물 처리공정에 적합한 고도산화공정 중 하나인 자외선/과산화수소공정의 효율적인 운전을 위한 최적 운전 조건을 도출하는 방법을 연구하였다. 자외선/과산화수소 공정에서 대상물질의 제거효율을 예측하고 그에 따른 운전조건을 도출하기 위한 핵심 인자인 수산화라디칼 소모인자를 보다 쉽고 빠르게 측정하기 위해 새로운 지표물질인 로다민 비(Rhodamin B, RhB)를 선정하여 검증하였다. 그 결과, 기존 지표물질인 para-Chlorobenzoic acid (pCBA)와 비교해 약 1.1% 이하의 오차율로 높은 신뢰성을 가진 것을 확인하였다. 검증된 RhB를 이용하여 측정한 수산화라디칼 소모인자 및 모델링을 통해 대상물질(Ibuprofen)의 제거효율 예측 가능성을 평가한 결과, 실제 실험값과 평균 오차율 약 5% 내외로 거의 일치하였다. 약 8개월간의 자외선/과산화수소공정 파일럿 플랜트 유입수의 수산화라디칼 소모인자 모니터링 결과, 최대 두 배 정도의 차이로 크게 변화하였다. 이 차이는 미량오염물질 중 하나인 Caffeine의 목표 제거율을 만족하기 위한 자외선 에너지를 약 1.7배 증가시켜야 할 정도로 큰 값이다. 이상의 결과를 통해 자외선/과산화수소 공정을 안전하고 효율적으로 운전하기 위해서는 수산화라디칼 소모인자의 측정이 매우 중요하며, 측정된 소모인자, 자외선 흡광도($A_{254}$), 대상물질의 정보만 입력하면 자외선/과산화수소 공정을 쉽게 제어할 수 있음을 확인하였다.

Down-regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Enhances Gensenoside Rh2 Pharmacological Action on Leukemia KG1α Cells

  • You, Zhi-Mei;Zhao, Liang;Xia, Jing;Wei, Qiang;Liu, Yu-Min;Liu, Xiao-Yan;Chen, Di-Long;Li, Jing
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권3호
    • /
    • pp.1099-1104
    • /
    • 2014
  • Aims and Background: Ginsenoside Rh2, which exerts the potent anticancer action both in vitro and in vivo, is one of the most well characterized ginsenosides extracted from ginseng. Although its effects on cancer are significant, the underlying mechanisms remain unknown. In this study, we sought to elucidate possible links between ginsenoside Rh2 and phosphoglucose isomerase/autocrine motility factor (PGI/AMF). Methods: $KG1{\alpha}$, a leukemia cell line highly expressing PGI/AMF was assessed by western blot analysis and reverse transcription- PCR (RT-PCR) assay after transfection of a small interfering (si)-RNA to silence PGI/AMF. The effect of PGI/AMF on proliferation was measured by typan blue assay and antibody array. A cell counting kit (CCK)-8 and flow cytometry (FCM) were adopted to investigate the effects of Rh2 on PGI/AMF. The relationships between PGI/AMF and Rh2 associated with Akt, mTOR, Raptor, Rag were detected by western blot analysis. Results: KG1${\alpha}$ cells expressed PGI/AMF and its down-regulation significantly inhibited proliferation. The antibody array indicated that the probable mechanism was reduced expression of PARP, State1, SAPK/JNK and Erk1/2, while those of PRAS40 and p38 were up-regulated. Silencing of PGI/AMF enhanced the sensibility of $KG1{\alpha}$ to Rh2 by suppressing the expression of mTOR, Raptor and Akt. Conclusion: These results suggested that ginsenoside Rh2 suppressed the proliferation of $KG1{\alpha}$, the same as down-regulation of PGI/AMF. Down-regulation of PGI/AMF enhanced the pharmacological effects of ginsenoside Rh2 on KG1${\alpha}$ by reducing Akt/mTOR signaling.

대장균에서 증식속도 조절에 의한 수용성 재조합 인간 과립구 콜로니 촉진인자의 생산 (Production of Soluble Recombinant Human Granulocyte Colony Stimulating Factor in E. coli by Control of Growth Rate.)

  • 박세철;고인영;강희일
    • 한국미생물·생명공학회지
    • /
    • 제32권2호
    • /
    • pp.135-141
    • /
    • 2004
  • 인간 과립구 성장인자(hG-CSF)는 골수에서 생산되는 단백질로 호중구의 분화 및 생성을 촉진시키는 역할을 한다. 현재 재조합 hG-CSF는 암화학요법에 의한 호중구감소증, 골수이식시 호중구 감소증, 재생불량성 빈혈에 수반되는 호중구 감소증 등으로 적응증이 확대되고 있다. 본 연구에서는 OmpA signal sequence를 삽입하여 인간 과립구 성장인자(hG-CSF)가 분비발현되도록 고안된 T7 promoter 에 의하여 발현되는 pYRCl 발현백터를 제조하였다. E. coli BL2l (pYRCl) 발현시 $37^{\circ}C$에서 배양하는 경우 많은 양의 봉입체(aggregates)를 형성한다. 이에 비하여 $10\mu$M ucose를 포함하는 변형된 MBL배지에서 10 g/$\ell$IPTG를 유도물질로 7시간동안 $25^{\circ}C$에서 배양하였을 때 전체 periplasm단백질의 15%가 soluble rhG-CSF이었다. 또한, 유가식 배양방법을 사용하여 E. coli BL2l(pYRCl)에서 soluble rhG-CSF의 생산조건을 조사하였다. 유가식 배양에서 rhG-CSF의 발현량이 비증식속도를 $0.43 h^{-1}$ 에서 0.14 $h^{-1}$ 으로, 유도 배양시간을 최적화함으로써 rhG-CSF의 발현량이 4.4mg/$\ell$에서 24mg/$\ell$ 로 증가하였다.

Bone Healing in Ovariectomized-rabbit Calvarial Defect with Tricalcium Phosphate Coated with Recombinant Human Bone Morphogenetic Protein-2 Genetically Engineered in Escherichia coli

  • Kim, Jung-Han;Kim, Chang-Joo;Shin, Sang-Hun
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제36권2호
    • /
    • pp.37-49
    • /
    • 2014
  • Purpose: This study compares the bone formation ability of tricalcium phosphate (TCP) with and without recombinant human bone morphogenetic protein-2 (rhBMP-2) and assesses TCP as a carrier of rhBMP-2. Methods: Bilateral round defects (diameter: 8.0 mm) were formed in the cranium of eight New Zealand white rabbits. The defects were grafted with TCP only (control group) or with rhBMP-2-coated TCP (experimental group). The animals were sacrificed at 1st week, 2nd week, 4th week, and 8th week postoperatively; two rabbits sacrificed each time. The skulls were harvested and subjected to radiographic and histological examination. Results: Radiologic evaluation showed faster bone remodeling in the experimental group than in the control group. Histologic evaluation (H&E, Masson's trichrome stain) showed rapid bone formation, remodeling and calcification in the 1st and 2nd week in the experimental group. Immunohistochemical evaluation showed higher expression rate of osteoprotegerin, receptor activator of nuclear factor ${\kappa}B$ ligand, and receptor activator of nuclear factor ${\kappa}B$ in the experimental group at the 1st and 2nd week than in the control group. Conclusion: rhBMP-2 coated TCP resulted in rapid bone formation, remodeling, and calcification due to rhBMP-2's osteogenic effect. TCP performed properly as a carrier for rhBMP-2. Thus, the use of an rhBMP-2 coating on TCP had a synergic effect on bone healing and, especially, bone remodeling and maturation.

Multivesicular DepoFoam particles for oral delivery of recombinant human epidermal growth factor

  • Li, Hong;An, Jun-Hee;Park, Jeong-Sook;Han, Kun
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
    • /
    • pp.299.1-299.1
    • /
    • 2003
  • Multivesicular DepoFoam technology is best suited for the encapsulation and sustained release of water-soluble drugs. The purpose of the present study was to prepare multivesicular DepoFoam particles and investigated possibility of oral delivery of a peptide, human epidermal growth factor (rhEGF). The multivesicular DepoFoam particles containing rhEGF was prepared by a two step water-in-oil-in-water double emulsification process. (omitted)

  • PDF